Beiersdorf and Macro Biologics, a US bioengineering company, have entered into a multi-year partnership to collaborate on the development of biodegradable antimicrobial peptides with broad application possibilities in skin care and healthcare. At the same time, Beiersdorf joins Macro Biologics as an investor through its venture capital unit Oscar & Paul Corporate.
Collaboration in this dynamic research area will focus on the use of Macro Biologics' antimicrobial "amicidins" in the development of Beiersdorf's innovative products and formulas. Aminicidins act against a wide variety of bacteria: they can help relieve or improve skin conditions, and are also designed for early topical application in the prevention of wound infections.
The common goal is to create highly effective, safe and sustainable solutions for a variety of application areas within Beiersdorf's brand portfolio, primarily in dermatology and healthcare.
"Through our collaboration with Macro Biologics, we are strengthening Beiersdorf's capacity for innovation, in line with our "Win with Care" strategy, as well as our ambition to remain a leader in the field of climate protection, said Dr Gitta Neufang, Beiersdorf Senior Vice President, Global Research and Development. We are delighted to have found an outstanding partner in this promising field of antimicrobial peptides, who shares our visionary drive for innovation. We look forward to jointly introducing Macro Biologics' advanced technology to the world of skin care and healthcare."
"We are very pleased to partner with Beiersdorf, a global skin care and health giant," said Dr. Michael BevilacquaGeneral Manager and Scientific Director of Macro Biologics. For Macro, this collaboration is a perfect fit, both from a research and a commercial point of view. Beiersdorf's in-depth expertise in product formulation, development and commercialization will enable amicidins to improve people's lives in a variety of contexts. This partnership is based on shared principles, as we both strive to create sustainable value for people and the environment."
